<< Insurers describe coverage of abortion in states with separate premiums | GTCR invests in ATI Holdings >>

Regado Biosciences announces first successful subcutaneous application of an aptamer

Published on March 15, 2010 at 10:40 AM · No Comments

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Chris Rusconi, PhD, Senior Vice President, Chief Scientific Officer and Steven Zelenkofske, DO, FACC, Senior Vice President , Chief Medical Officer presented an abstract at the American College of Cardiology on Monday, March 15, 2010 in Atlanta, Georgia.

Continued on Next page >>

NIH awards $3.2M for development of highly efficient system of generating nucleic acid moleculesThe National Institutes of Health (NIH) has awarded $3.2 million to a team of preeminent engineering...
New microplate for BioFlux live cell imaging workstationsFluxion Biosciences introduces a new microplate for its BioFlux live cell imaging workstations, exte...
EPO issues grant for a patent in Kreutzer-Limmer III patent seriesAlnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Europea...
FDA approves Hospira's six new vial presentations of heparinHospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced t...
Leicester research reveals the detrimental effects of Beta blockers on central aortic pressuresA University of Leicester-led study may have uncovered the reason why Beta-blockers are less effecti...
Abnormal "editing" of gene messages may cause LupusResearchers at Wake Forest University have uncovered evidence that the abnormal "editing" of gene me...
Evaluation of primary urinary tract infection in infantsThey reviewed the clinical and laboratory findings as well as the diagnosis and treatment. This stud...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.